Biomerica (BMRA) announced that its Fortel Kidney Disease Test has been approved for sale by the United Arab Emirates Ministry of Health and Prevention. This key regulatory milestone enables Biomerica to offer its test across the UAE, a region facing a high burden of chronic kidney disease.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRA: